Decreased expression of MT1E is a potential biomarker of prostate cancer progression.

about

The roles of metallothioneins in carcinogenesis

P2860

Q58713688-E7016630-08DC-4E67-879B-58148B9CF855

P2860

Decreased expression of MT1E is a potential biomarker of prostate cancer progression.

Item

http://www.wikidata.org/entity/Q42096711

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Decreased expression of MT1E is a potential biomarker of prostate cancer progression.

@en

Decreased expression of MT1E is a potential biomarker of prostate cancer progression.

@nl

type

Item

label

Decreased expression of MT1E is a potential biomarker of prostate cancer progression.

@en

Decreased expression of MT1E is a potential biomarker of prostate cancer progression.

@nl

prefLabel

Decreased expression of MT1E is a potential biomarker of prostate cancer progression.

@en

Decreased expression of MT1E is a potential biomarker of prostate cancer progression.

@nl

P1476

Decreased expression of MT1E is a potential biomarker of prostate cancer progression

@en

P2093

Aiste Skeberdyte

http://www.w3.org/2001/XMLSchema#string

Arnas Bakavicius

http://www.w3.org/2001/XMLSchema#string

Donatas Petroska

http://www.w3.org/2001/XMLSchema#string

Feliksas Jankevicius

http://www.w3.org/2001/XMLSchema#string

Juozas R Lazutka

http://www.w3.org/2001/XMLSchema#string

Rasa Sabaliauskaite

http://www.w3.org/2001/XMLSchema#string

Rita Demidenko

http://www.w3.org/2001/XMLSchema#string

Sonata Jarmalaite

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer -what has gone wrong? A blueprint for the way forward in biomarker studies

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1

Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.

SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression.

Regulators of gene expression as biomarkers for prostate cancer

The role of metallothionein in oncogenesis and cancer prognosis

EZH2, an epigenetic driver of prostate cancer.

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

P304

61709-61718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18683

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Arvydas Laurinavicius

Kristina Daniunaite

P577

2017-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28977898

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5617458

http://www.w3.org/2001/XMLSchema#string

Decreased expression of MT1E is a potential biomarker of prostate cancer progression.

about

P2860

P2860

Decreased expression of MT1E is a potential biomarker of prostate cancer progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932